Latest Insider Transactions at Ashland Global Holdings Inc (ASH)
This section provides a real-time view of insider transactions for Ashland Global Holdings Inc (ASH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ASHLAND GLOBAL HOLDINGS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ASHLAND GLOBAL HOLDINGS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2025
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-1.41%
|
$3,528
$49.6 P/Share
|
|
Nov 17
2025
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
BUY
Exercise of conversion of derivative security
|
Direct |
239
+4.48%
|
$11,711
$49.6 P/Share
|
|
Nov 17
2025
|
William Whitaker SVP, CFO & PFO |
SELL
Payment of exercise price or tax liability
|
Direct |
33
-1.59%
|
$1,617
$49.6 P/Share
|
|
Nov 17
2025
|
William Whitaker SVP, CFO & PFO |
BUY
Exercise of conversion of derivative security
|
Direct |
107
+4.89%
|
$5,243
$49.6 P/Share
|
|
Nov 17
2025
|
Samuel Richardson VP, Controller and PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-2.9%
|
$1,568
$49.6 P/Share
|
|
Nov 17
2025
|
Samuel Richardson VP, Controller and PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
107
+8.84%
|
$5,243
$49.6 P/Share
|
|
Nov 17
2025
|
Osama M Musa SVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-1.12%
|
$16,415
$49.6 P/Share
|
|
Nov 17
2025
|
Osama M Musa SVP and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
976
+3.16%
|
$47,824
$49.6 P/Share
|
|
Nov 17
2025
|
Eileen Drury SVP and Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
280
-3.55%
|
$13,720
$49.6 P/Share
|
|
Nov 17
2025
|
Eileen Drury SVP and Chief HRO |
BUY
Exercise of conversion of derivative security
|
Direct |
567
+6.71%
|
$27,783
$49.6 P/Share
|
|
Nov 17
2025
|
Guillermo Novo Chair of the Board and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,563
-1.79%
|
$125,587
$49.6 P/Share
|
|
Nov 17
2025
|
Guillermo Novo Chair of the Board and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,122
+4.09%
|
$299,978
$49.6 P/Share
|
|
Nov 14
2025
|
Osama M Musa SVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
717
-2.42%
|
$36,567
$51.51 P/Share
|
|
Nov 14
2025
|
Osama M Musa SVP and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,091
+6.59%
|
$106,641
$51.51 P/Share
|
|
Nov 14
2025
|
Guillermo Novo Chair of the Board and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-2.71%
|
$194,667
$51.51 P/Share
|
|
Nov 14
2025
|
Guillermo Novo Chair of the Board and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,119
+6.07%
|
$465,069
$51.51 P/Share
|
|
Nov 14
2025
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
SELL
Payment of exercise price or tax liability
|
Direct |
381
-7.28%
|
$19,431
$51.51 P/Share
|
|
Nov 14
2025
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,276
+19.59%
|
$65,076
$51.51 P/Share
|
|
Nov 14
2025
|
Samuel Richardson VP, Controller and PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-6.47%
|
$3,519
$51.51 P/Share
|
|
Nov 14
2025
|
Samuel Richardson VP, Controller and PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
228
+17.62%
|
$11,628
$51.51 P/Share
|
|
Nov 14
2025
|
William Whitaker SVP, CFO & PFO |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-5.18%
|
$5,508
$51.51 P/Share
|
|
Nov 14
2025
|
William Whitaker SVP, CFO & PFO |
BUY
Exercise of conversion of derivative security
|
Direct |
356
+14.6%
|
$18,156
$51.51 P/Share
|
|
Nov 14
2025
|
James P. Minicucci SVP and GM, Personal Care |
SELL
Payment of exercise price or tax liability
|
Direct |
383
-8.25%
|
$19,533
$51.51 P/Share
|
|
Nov 14
2025
|
James P. Minicucci SVP and GM, Personal Care |
BUY
Exercise of conversion of derivative security
|
Direct |
1,225
+20.89%
|
$62,475
$51.51 P/Share
|
|
Nov 14
2025
|
Eileen Drury SVP and Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
603
-7.62%
|
$30,753
$51.51 P/Share
|
|
Nov 14
2025
|
Eileen Drury SVP and Chief HRO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,297
+14.08%
|
$66,147
$51.51 P/Share
|
|
Nov 13
2025
|
Osama M Musa SVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
477
-1.7%
|
$25,281
$53.1 P/Share
|
|
Nov 13
2025
|
Osama M Musa SVP and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,393
+4.74%
|
$73,829
$53.1 P/Share
|
|
Nov 13
2025
|
Guillermo Novo Chair of the Board and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,779
-2.78%
|
$200,287
$53.1 P/Share
|
|
Nov 13
2025
|
Guillermo Novo Chair of the Board and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,029
+6.24%
|
$478,537
$53.1 P/Share
|
|
Nov 13
2025
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-6.14%
|
$13,727
$53.1 P/Share
|
|
Nov 13
2025
|
Robin E. Lampkin SVP, Gen Counsel and Secrty. |
BUY
Exercise of conversion of derivative security
|
Direct |
866
+17.03%
|
$45,898
$53.1 P/Share
|
|
Nov 13
2025
|
Samuel Richardson VP, Controller and PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
44
-4.99%
|
$2,332
$53.1 P/Share
|
|
Nov 13
2025
|
Samuel Richardson VP, Controller and PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
146
+14.2%
|
$7,738
$53.1 P/Share
|
|
Nov 13
2025
|
William Whitaker SVP, CFO & PFO |
SELL
Payment of exercise price or tax liability
|
Direct |
70
-3.9%
|
$3,710
$53.1 P/Share
|
|
Nov 13
2025
|
William Whitaker SVP, CFO & PFO |
BUY
Exercise of conversion of derivative security
|
Direct |
229
+11.3%
|
$12,137
$53.1 P/Share
|
|
Nov 13
2025
|
Dago Caceres SVP & GM, Specialty Additives |
SELL
Payment of exercise price or tax liability
|
Direct |
215
-28.82%
|
$11,395
$53.1 P/Share
|
|
Nov 13
2025
|
Dago Caceres SVP & GM, Specialty Additives |
BUY
Exercise of conversion of derivative security
|
Direct |
746
+50.0%
|
$39,538
$53.1 P/Share
|
|
Nov 13
2025
|
Alessandra Faccin Assis SVP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
570
-9.07%
|
$30,210
$53.1 P/Share
|
|
Nov 13
2025
|
Alessandra Faccin Assis SVP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
1,340
+17.57%
|
$71,020
$53.1 P/Share
|
|
Nov 13
2025
|
James P. Minicucci SVP and GM, Personal Care |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-8.54%
|
$16,907
$53.1 P/Share
|
|
Nov 13
2025
|
James P. Minicucci SVP and GM, Personal Care |
BUY
Exercise of conversion of derivative security
|
Direct |
1,020
+21.46%
|
$54,060
$53.1 P/Share
|
|
Nov 13
2025
|
Eileen Drury SVP and Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-5.7%
|
$21,200
$53.1 P/Share
|
|
Nov 13
2025
|
Eileen Drury SVP and Chief HRO |
BUY
Exercise of conversion of derivative security
|
Direct |
863
+10.95%
|
$45,739
$53.1 P/Share
|
|
Jul 25
2025
|
Alessandra Faccin Assis SVP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
1,327
-21.15%
|
$67,677
$51.26 P/Share
|
|
Jul 25
2025
|
Alessandra Faccin Assis SVP and GM, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
3,123
+33.24%
|
$159,273
$51.26 P/Share
|
|
May 08
2025
|
James P. Minicucci SVP and GM, Personal Care |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-13.81%
|
$21,315
$49.99 P/Share
|
|
May 08
2025
|
James P. Minicucci SVP and GM, Personal Care |
BUY
Exercise of conversion of derivative security
|
Direct |
1,395
+30.7%
|
$68,355
$49.99 P/Share
|
|
May 06
2025
|
Ashish K Kulkarni |
BUY
Exercise of conversion of derivative security
|
Direct |
1,032
+50.0%
|
-
|
|
Jan 31
2025
|
Alessandra Faccin Assis SVP and GM, Life Sciences |
BUY
Open market or private purchase
|
Direct |
3,150
+50.0%
|
$201,600
$64.0 P/Share
|